These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3320900)

  • 41. The treatment of salmonellosis in Equidae.
    Morse EV; Duncan MA; Fessler JF; Page EH
    Mod Vet Pract; 1976 Jan; 57(1):47-51. PubMed ID: 1246235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of ceftriaxone with standard therapy for bacterial meningitis.
    Steele RW; Bradsher RW
    J Pediatr; 1983 Jul; 103(1):138-41. PubMed ID: 6306192
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of antibacterials on experimentally induced Salmonella typhimurium infection in chickens.
    MacKenzie MM; Bains BS
    Poult Sci; 1974 Jan; 53(1):307-10. PubMed ID: 4597375
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B; Coban AY; Birinci A; Durupinar B; Erturk M
    Clin Microbiol Infect; 2002 Dec; 8(12):810-3. PubMed ID: 12519356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.
    Butler T; Shuster CW; Dixon P
    Antimicrob Agents Chemother; 1981 Feb; 19(2):328-31. PubMed ID: 6289730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
    Fattal E; Youssef M; Couvreur P; Andremont A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1540-3. PubMed ID: 2684009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined use of quinolones with other antibiotics in treatment of experimental plague infection].
    Shcherbaniuk AI; Kasatkina IV; Ryzhko IV
    Antibiot Khimioter; 1994 May; 39(5):38-40. PubMed ID: 7857159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pefloxacin in the treatment of lower respiratory tract infections in geriatrics.
    Vanderdonckt J
    J Int Med Res; 1987; 15(4):234-9. PubMed ID: 3477513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue dyslipidemia in Salmonella-infected rats treated with amoxillin and pefloxacin.
    Rotimi SO; Ojo DA; Talabi OA; Balogun EA; Ademuyiwa O
    Lipids Health Dis; 2012 Nov; 11():152. PubMed ID: 23137290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
    Pilmis B; Jiang O; Mizrahi A; Nguyen Van JC; Lourtet-Hascoët J; Voisin O; Le Lorc'h E; Hubert S; Ménage E; Azria P; Borie MF; Mahé A; Mourad JJ; Trabattoni E; Ganansia O; Zahar JR; Le Monnier A
    Int J Infect Dis; 2021 Mar; 104():617-623. PubMed ID: 33453395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salmonella meningitis in Thai infants: clinical case reports.
    Visudhiphan P; Chiemchanya S; Visutibhan A
    Trans R Soc Trop Med Hyg; 1998; 92(2):181-4. PubMed ID: 9764327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS; Lasserre R
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addendum for Meningitis.
    Rathore MH
    Pediatr Rev; 2016 Apr; 37(4):158. PubMed ID: 27037101
    [No Abstract]   [Full Text] [Related]  

  • 54. Disease associated with S typhimurium in cattle.
    Tutt JB; Hoare DI
    Vet Rec; 1974 Oct; 95(15):334-7. PubMed ID: 4615426
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
    Lauwers S; Vincken W; Naessens A; Pierard D
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():111-5. PubMed ID: 3458696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
    Burdet C; Grall N; Linard M; Bridier-Nahmias A; Benhayoun M; Bourabha K; Magnan M; Clermont O; d'Humières C; Tenaillon O; Denamur E; Massias L; Tubiana S; Alavoine L; Andremont A; Mentré F; Duval X;
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
    Thomas P; Daly S; Misan G; Steele T
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Eradication of asymptomatic carrier state of non-typhoid Salmonella with two doses of pefloxacin].
    Gendrel D; Raymond J; Moulin F; Habib F; Iniguez JL; Chemillier-Truong M; Badoual J
    Arch Pediatr; 1995 May; 2(5):418-22. PubMed ID: 7640732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The chemotherapy of experimental Salmonella choleraesuis infetion in mice.
    Chung GT; Frost AJ
    J Med Microbiol; 1970 May; 3(2):303-11. PubMed ID: 5452463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.